Literature DB >> 8557696

Overexpression of thymidine kinase mRNA eliminates cell cycle regulation of thymidine kinase enzyme activity.

W Mikulits1, M Hengstschläger, T Sauer, E Wintersberger, E W Müllner.   

Abstract

Expression of thymidine kinase (TK) enzyme activity and mRNA is strictly S phase-specific in primary cells. In contrast, DNA tumor virus-transformed cells have enhanced and constitutive levels of TK mRNA during the whole cell cycle. Their TK protein abundance, however, still increases at the G1-S transition and stays high throughout G2 until mitosis. Therefore, post-transcriptional control must account for the decoupling of TK mRNA from protein synthesis in G1. To characterize the underlying mechanism, we studied the consequences of TK mRNA abundance on the cell cycle-dependent regulation of TK activity in nontransformed cells. Constitutive as well as conditional human and mouse TK cDNA vectors were stably transfected into mouse fibroblasts, which were subsequently synchronized by centrifugal elutriation. Low constitutive TK mRNA expression still resulted in a fluctuation of TK activity with a pronounced maximum in S phase. This pattern of cell cycle-dependent TK activity variation reflected the one in primary cell but is caused by post-transcriptional control. Increasing overexpression of TK transcripts after hormonal induction compromised this regulation. At the highest constant mRNA levels, regulation of enzyme activity was totally abolished in each phase of the cell cycle. These data indicate that post-transcriptional regulation of TK is tightly coupled to the amount of mRNA; high concentrations apparently titrate a factor(s) required for repressing TK production during G1 and presumably also G2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557696     DOI: 10.1074/jbc.271.2.853

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene.

Authors:  M I Darville; G G Rousseau
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

2.  Long noncoding RNA HOXC-AS3 indicates a poor prognosis and regulates tumorigenesis by binding to YBX1 in breast cancer.

Authors:  Jun Su; Bo Yu; Chongguo Zhang; Peiqiang Yi; Huan Li; Cheng Xu; Lu Cao; Peizhan Chen; Min Li; Kunwei Shen; Jiayi Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  Degradation of human thymidine kinase is dependent on serine-13 phosphorylation: involvement of the SCF-mediated pathway.

Authors:  Po-Yuan Ke; Che-Chuan Yang; I-Chun Tsai; Zee-Fen Chang
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

4.  Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

Authors:  Neale S Mason; Brian J Lopresti; James Ruszkiewicz; Xinxin Dong; Sonali Joyce; George Leef; Malabika Sen; Abdus S Wahed; Chester A Mathis; Jennifer R Grandis; Sufi M Thomas
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

5.  Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.

Authors:  J Scott Brockenbrough; Janice K Morihara; Stephen E Hawes; Joshua E Stern; Janet S Rasey; Linda W Wiens; Qinghua Feng; Hubert Vesselle
Journal:  J Histochem Cytochem       Date:  2009-08-03       Impact factor: 2.479

Review 6.  Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.

Authors:  R Adam Smith; Saffet Guleryuz; H Charles Manning
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

7.  Thymidine kinase 1 upregulation is an early event in breast tumor formation.

Authors:  Melissa M Alegre; Richard A Robison; Kim L O'Neill
Journal:  J Oncol       Date:  2012-06-19       Impact factor: 4.375

8.  Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.

Authors:  Tanya C Burch; Megan T Watson; Julius O Nyalwidhe
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging.

Authors:  Peter J O'Brien; Michelle Lee; Mary E Spilker; Cathy C Zhang; Zhengming Yan; Timothy C Nichols; Wenlin Li; Caroline H Johnson; Gary J Patti; Gary Siuzdak
Journal:  Cancer Metab       Date:  2013-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.